BindingDB Reactant_set_id	Ligand SMILES	Ligand InChI	Ligand InChI Key	BindingDB MonomerID	BindingDB Ligand Name	Target Name	Target Source Organism According to Curator or DataSource	Ki (nM)	IC50 (nM)	Kd (nM)	EC50 (nM)	kon (M-1-s-1)	koff (s-1)	pH	Temp (C)	Curation/DataSource	Article DOI	BindingDB Entry DOI	PMID	PubChem AID	Patent Number	Authors	Date of publication	Date in BindingDB	Institution	Link to Ligand in BindingDB	Link to Target in BindingDB	Link to Ligand-Target Pair in BindingDB	Ligand HET ID in PDB	PDB ID(s) for Ligand-Target Complex	PubChem CID	PubChem SID	ChEBI ID of Ligand	ChEMBL ID of Ligand	DrugBank ID of Ligand	IUPHAR_GRAC ID of Ligand	KEGG ID of Ligand	ZINC ID of Ligand	Number of Protein Chains in Target (>1 implies a multichain complex)	BindingDB Target Chain Sequence 1	PDB ID(s) of Target Chain 1	UniProt (SwissProt) Recommended Name of Target Chain 1	UniProt (SwissProt) Entry Name of Target Chain 1	UniProt (SwissProt) Primary ID of Target Chain 1	UniProt (SwissProt) Secondary ID(s) of Target Chain 1	UniProt (SwissProt) Alternative ID(s) of Target Chain 1	UniProt (TrEMBL) Submitted Name of Target Chain 1	UniProt (TrEMBL) Entry Name of Target Chain 1	UniProt (TrEMBL) Primary ID of Target Chain 1	UniProt (TrEMBL) Secondary ID(s) of Target Chain 1	UniProt (TrEMBL) Alternative ID(s) of Target Chain 1	BindingDB Target Chain Sequence 2	PDB ID(s) of Target Chain 2	UniProt (SwissProt) Recommended Name of Target Chain 2	UniProt (SwissProt) Entry Name of Target Chain 2	UniProt (SwissProt) Primary ID of Target Chain 2	UniProt (SwissProt) Secondary ID(s) of Target Chain 2	UniProt (SwissProt) Alternative ID(s) of Target Chain 2	UniProt (TrEMBL) Submitted Name of Target Chain 2	UniProt (TrEMBL) Entry Name of Target Chain 2	UniProt (TrEMBL) Primary ID of Target Chain 2	UniProt (TrEMBL) Secondary ID(s) of Target Chain 2	UniProt (TrEMBL) Alternative ID(s) of Target Chain 2	BindingDB Target Chain Sequence 3	PDB ID(s) of Target Chain 3	UniProt (SwissProt) Recommended Name of Target Chain 3	UniProt (SwissProt) Entry Name of Target Chain 3	UniProt (SwissProt) Primary ID of Target Chain 3	UniProt (SwissProt) Secondary ID(s) of Target Chain 3	UniProt (SwissProt) Alternative ID(s) of Target Chain 3	UniProt (TrEMBL) Submitted Name of Target Chain 3	UniProt (TrEMBL) Entry Name of Target Chain 3	UniProt (TrEMBL) Primary ID of Target Chain 3	UniProt (TrEMBL) Secondary ID(s) of Target Chain 3	UniProt (TrEMBL) Alternative ID(s) of Target Chain 3	BindingDB Target Chain Sequence 4	PDB ID(s) of Target Chain 4	UniProt (SwissProt) Recommended Name of Target Chain 4	UniProt (SwissProt) Entry Name of Target Chain 4	UniProt (SwissProt) Primary ID of Target Chain 4	UniProt (SwissProt) Secondary ID(s) of Target Chain 4	UniProt (SwissProt) Alternative ID(s) of Target Chain 4	UniProt (TrEMBL) Submitted Name of Target Chain 4	UniProt (TrEMBL) Entry Name of Target Chain 4	UniProt (TrEMBL) Primary ID of Target Chain 4	UniProt (TrEMBL) Secondary ID(s) of Target Chain 4	UniProt (TrEMBL) Alternative ID(s) of Target Chain 4	BindingDB Target Chain Sequence 5	PDB ID(s) of Target Chain 5	UniProt (SwissProt) Recommended Name of Target Chain 5	UniProt (SwissProt) Entry Name of Target Chain 5	UniProt (SwissProt) Primary ID of Target Chain 5	UniProt (SwissProt) Secondary ID(s) of Target Chain 5	UniProt (SwissProt) Alternative ID(s) of Target Chain 5	UniProt (TrEMBL) Submitted Name of Target Chain 5	UniProt (TrEMBL) Entry Name of Target Chain 5	UniProt (TrEMBL) Primary ID of Target Chain 5	UniProt (TrEMBL) Secondary ID(s) of Target Chain 5	UniProt (TrEMBL) Alternative ID(s) of Target Chain 5	BindingDB Target Chain Sequence 6	PDB ID(s) of Target Chain 6	UniProt (SwissProt) Recommended Name of Target Chain 6	UniProt (SwissProt) Entry Name of Target Chain 6	UniProt (SwissProt) Primary ID of Target Chain 6	UniProt (SwissProt) Secondary ID(s) of Target Chain 6	UniProt (SwissProt) Alternative ID(s) of Target Chain 6	UniProt (TrEMBL) Submitted Name of Target Chain 6	UniProt (TrEMBL) Entry Name of Target Chain 6	UniProt (TrEMBL) Primary ID of Target Chain 6	UniProt (TrEMBL) Secondary ID(s) of Target Chain 6	UniProt (TrEMBL) Alternative ID(s) of Target Chain 6	BindingDB Target Chain Sequence 7	PDB ID(s) of Target Chain 7	UniProt (SwissProt) Recommended Name of Target Chain 7	UniProt (SwissProt) Entry Name of Target Chain 7	UniProt (SwissProt) Primary ID of Target Chain 7	UniProt (SwissProt) Secondary ID(s) of Target Chain 7	UniProt (SwissProt) Alternative ID(s) of Target Chain 7	UniProt (TrEMBL) Submitted Name of Target Chain 7	UniProt (TrEMBL) Entry Name of Target Chain 7	UniProt (TrEMBL) Primary ID of Target Chain 7	UniProt (TrEMBL) Secondary ID(s) of Target Chain 7	UniProt (TrEMBL) Alternative ID(s) of Target Chain 7	BindingDB Target Chain Sequence 8	PDB ID(s) of Target Chain 8	UniProt (SwissProt) Recommended Name of Target Chain 8	UniProt (SwissProt) Entry Name of Target Chain 8	UniProt (SwissProt) Primary ID of Target Chain 8	UniProt (SwissProt) Secondary ID(s) of Target Chain 8	UniProt (SwissProt) Alternative ID(s) of Target Chain 8	UniProt (TrEMBL) Submitted Name of Target Chain 8	UniProt (TrEMBL) Entry Name of Target Chain 8	UniProt (TrEMBL) Primary ID of Target Chain 8	UniProt (TrEMBL) Secondary ID(s) of Target Chain 8	UniProt (TrEMBL) Alternative ID(s) of Target Chain 8	BindingDB Target Chain Sequence 9	PDB ID(s) of Target Chain 9	UniProt (SwissProt) Recommended Name of Target Chain 9	UniProt (SwissProt) Entry Name of Target Chain 9	UniProt (SwissProt) Primary ID of Target Chain 9	UniProt (SwissProt) Secondary ID(s) of Target Chain 9	UniProt (SwissProt) Alternative ID(s) of Target Chain 9	UniProt (TrEMBL) Submitted Name of Target Chain 9	UniProt (TrEMBL) Entry Name of Target Chain 9	UniProt (TrEMBL) Primary ID of Target Chain 9	UniProt (TrEMBL) Secondary ID(s) of Target Chain 9	UniProt (TrEMBL) Alternative ID(s) of Target Chain 9	BindingDB Target Chain Sequence 10	PDB ID(s) of Target Chain 10	UniProt (SwissProt) Recommended Name of Target Chain 10	UniProt (SwissProt) Entry Name of Target Chain 10	UniProt (SwissProt) Primary ID of Target Chain 10	UniProt (SwissProt) Secondary ID(s) of Target Chain 10	UniProt (SwissProt) Alternative ID(s) of Target Chain 10	UniProt (TrEMBL) Submitted Name of Target Chain 10	UniProt (TrEMBL) Entry Name of Target Chain 10	UniProt (TrEMBL) Primary ID of Target Chain 10	UniProt (TrEMBL) Secondary ID(s) of Target Chain 10	UniProt (TrEMBL) Alternative ID(s) of Target Chain 10	BindingDB Target Chain Sequence 11	PDB ID(s) of Target Chain 11	UniProt (SwissProt) Recommended Name of Target Chain 11	UniProt (SwissProt) Entry Name of Target Chain 11	UniProt (SwissProt) Primary ID of Target Chain 11	UniProt (SwissProt) Secondary ID(s) of Target Chain 11	UniProt (SwissProt) Alternative ID(s) of Target Chain 11	UniProt (TrEMBL) Submitted Name of Target Chain 11	UniProt (TrEMBL) Entry Name of Target Chain 11	UniProt (TrEMBL) Primary ID of Target Chain 11	UniProt (TrEMBL) Secondary ID(s) of Target Chain 11	UniProt (TrEMBL) Alternative ID(s) of Target Chain 11	BindingDB Target Chain Sequence 12	PDB ID(s) of Target Chain 12	UniProt (SwissProt) Recommended Name of Target Chain 12	UniProt (SwissProt) Entry Name of Target Chain 12	UniProt (SwissProt) Primary ID of Target Chain 12	UniProt (SwissProt) Secondary ID(s) of Target Chain 12	UniProt (SwissProt) Alternative ID(s) of Target Chain 12	UniProt (TrEMBL) Submitted Name of Target Chain 12	UniProt (TrEMBL) Entry Name of Target Chain 12	UniProt (TrEMBL) Primary ID of Target Chain 12	UniProt (TrEMBL) Secondary ID(s) of Target Chain 12	UniProt (TrEMBL) Alternative ID(s) of Target Chain 12	BindingDB Target Chain Sequence 13	PDB ID(s) of Target Chain 13	UniProt (SwissProt) Recommended Name of Target Chain 13	UniProt (SwissProt) Entry Name of Target Chain 13	UniProt (SwissProt) Primary ID of Target Chain 13	UniProt (SwissProt) Secondary ID(s) of Target Chain 13	UniProt (SwissProt) Alternative ID(s) of Target Chain 13	UniProt (TrEMBL) Submitted Name of Target Chain 13	UniProt (TrEMBL) Entry Name of Target Chain 13	UniProt (TrEMBL) Primary ID of Target Chain 13	UniProt (TrEMBL) Secondary ID(s) of Target Chain 13	UniProt (TrEMBL) Alternative ID(s) of Target Chain 13	BindingDB Target Chain Sequence 14	PDB ID(s) of Target Chain 14	UniProt (SwissProt) Recommended Name of Target Chain 14	UniProt (SwissProt) Entry Name of Target Chain 14	UniProt (SwissProt) Primary ID of Target Chain 14	UniProt (SwissProt) Secondary ID(s) of Target Chain 14	UniProt (SwissProt) Alternative ID(s) of Target Chain 14	UniProt (TrEMBL) Submitted Name of Target Chain 14	UniProt (TrEMBL) Entry Name of Target Chain 14	UniProt (TrEMBL) Primary ID of Target Chain 14	UniProt (TrEMBL) Secondary ID(s) of Target Chain 14	UniProt (TrEMBL) Alternative ID(s) of Target Chain 14	BindingDB Target Chain Sequence 15	PDB ID(s) of Target Chain 15	UniProt (SwissProt) Recommended Name of Target Chain 15	UniProt (SwissProt) Entry Name of Target Chain 15	UniProt (SwissProt) Primary ID of Target Chain 15	UniProt (SwissProt) Secondary ID(s) of Target Chain 15	UniProt (SwissProt) Alternative ID(s) of Target Chain 15	UniProt (TrEMBL) Submitted Name of Target Chain 15	UniProt (TrEMBL) Entry Name of Target Chain 15	UniProt (TrEMBL) Primary ID of Target Chain 15	UniProt (TrEMBL) Secondary ID(s) of Target Chain 15	UniProt (TrEMBL) Alternative ID(s) of Target Chain 15	BindingDB Target Chain Sequence 16	PDB ID(s) of Target Chain 16	UniProt (SwissProt) Recommended Name of Target Chain 16	UniProt (SwissProt) Entry Name of Target Chain 16	UniProt (SwissProt) Primary ID of Target Chain 16	UniProt (SwissProt) Secondary ID(s) of Target Chain 16	UniProt (SwissProt) Alternative ID(s) of Target Chain 16	UniProt (TrEMBL) Submitted Name of Target Chain 16	UniProt (TrEMBL) Entry Name of Target Chain 16	UniProt (TrEMBL) Primary ID of Target Chain 16	UniProt (TrEMBL) Secondary ID(s) of Target Chain 16	UniProt (TrEMBL) Alternative ID(s) of Target Chain 16	BindingDB Target Chain Sequence 17	PDB ID(s) of Target Chain 17	UniProt (SwissProt) Recommended Name of Target Chain 17	UniProt (SwissProt) Entry Name of Target Chain 17	UniProt (SwissProt) Primary ID of Target Chain 17	UniProt (SwissProt) Secondary ID(s) of Target Chain 17	UniProt (SwissProt) Alternative ID(s) of Target Chain 17	UniProt (TrEMBL) Submitted Name of Target Chain 17	UniProt (TrEMBL) Entry Name of Target Chain 17	UniProt (TrEMBL) Primary ID of Target Chain 17	UniProt (TrEMBL) Secondary ID(s) of Target Chain 17	UniProt (TrEMBL) Alternative ID(s) of Target Chain 17	BindingDB Target Chain Sequence 18	PDB ID(s) of Target Chain 18	UniProt (SwissProt) Recommended Name of Target Chain 18	UniProt (SwissProt) Entry Name of Target Chain 18	UniProt (SwissProt) Primary ID of Target Chain 18	UniProt (SwissProt) Secondary ID(s) of Target Chain 18	UniProt (SwissProt) Alternative ID(s) of Target Chain 18	UniProt (TrEMBL) Submitted Name of Target Chain 18	UniProt (TrEMBL) Entry Name of Target Chain 18	UniProt (TrEMBL) Primary ID of Target Chain 18	UniProt (TrEMBL) Secondary ID(s) of Target Chain 18	UniProt (TrEMBL) Alternative ID(s) of Target Chain 18	BindingDB Target Chain Sequence 19	PDB ID(s) of Target Chain 19	UniProt (SwissProt) Recommended Name of Target Chain 19	UniProt (SwissProt) Entry Name of Target Chain 19	UniProt (SwissProt) Primary ID of Target Chain 19	UniProt (SwissProt) Secondary ID(s) of Target Chain 19	UniProt (SwissProt) Alternative ID(s) of Target Chain 19	UniProt (TrEMBL) Submitted Name of Target Chain 19	UniProt (TrEMBL) Entry Name of Target Chain 19	UniProt (TrEMBL) Primary ID of Target Chain 19	UniProt (TrEMBL) Secondary ID(s) of Target Chain 19	UniProt (TrEMBL) Alternative ID(s) of Target Chain 19	BindingDB Target Chain Sequence 20	PDB ID(s) of Target Chain 20	UniProt (SwissProt) Recommended Name of Target Chain 20	UniProt (SwissProt) Entry Name of Target Chain 20	UniProt (SwissProt) Primary ID of Target Chain 20	UniProt (SwissProt) Secondary ID(s) of Target Chain 20	UniProt (SwissProt) Alternative ID(s) of Target Chain 20	UniProt (TrEMBL) Submitted Name of Target Chain 20	UniProt (TrEMBL) Entry Name of Target Chain 20	UniProt (TrEMBL) Primary ID of Target Chain 20	UniProt (TrEMBL) Secondary ID(s) of Target Chain 20	UniProt (TrEMBL) Alternative ID(s) of Target Chain 20	BindingDB Target Chain Sequence 21	PDB ID(s) of Target Chain 21	UniProt (SwissProt) Recommended Name of Target Chain 21	UniProt (SwissProt) Entry Name of Target Chain 21	UniProt (SwissProt) Primary ID of Target Chain 21	UniProt (SwissProt) Secondary ID(s) of Target Chain 21	UniProt (SwissProt) Alternative ID(s) of Target Chain 21	UniProt (TrEMBL) Submitted Name of Target Chain 21	UniProt (TrEMBL) Entry Name of Target Chain 21	UniProt (TrEMBL) Primary ID of Target Chain 21	UniProt (TrEMBL) Secondary ID(s) of Target Chain 21	UniProt (TrEMBL) Alternative ID(s) of Target Chain 21	BindingDB Target Chain Sequence 22	PDB ID(s) of Target Chain 22	UniProt (SwissProt) Recommended Name of Target Chain 22	UniProt (SwissProt) Entry Name of Target Chain 22	UniProt (SwissProt) Primary ID of Target Chain 22	UniProt (SwissProt) Secondary ID(s) of Target Chain 22	UniProt (SwissProt) Alternative ID(s) of Target Chain 22	UniProt (TrEMBL) Submitted Name of Target Chain 22	UniProt (TrEMBL) Entry Name of Target Chain 22	UniProt (TrEMBL) Primary ID of Target Chain 22	UniProt (TrEMBL) Secondary ID(s) of Target Chain 22	UniProt (TrEMBL) Alternative ID(s) of Target Chain 22	BindingDB Target Chain Sequence 23	PDB ID(s) of Target Chain 23	UniProt (SwissProt) Recommended Name of Target Chain 23	UniProt (SwissProt) Entry Name of Target Chain 23	UniProt (SwissProt) Primary ID of Target Chain 23	UniProt (SwissProt) Secondary ID(s) of Target Chain 23	UniProt (SwissProt) Alternative ID(s) of Target Chain 23	UniProt (TrEMBL) Submitted Name of Target Chain 23	UniProt (TrEMBL) Entry Name of Target Chain 23	UniProt (TrEMBL) Primary ID of Target Chain 23	UniProt (TrEMBL) Secondary ID(s) of Target Chain 23	UniProt (TrEMBL) Alternative ID(s) of Target Chain 23	BindingDB Target Chain Sequence 24	PDB ID(s) of Target Chain 24	UniProt (SwissProt) Recommended Name of Target Chain 24	UniProt (SwissProt) Entry Name of Target Chain 24	UniProt (SwissProt) Primary ID of Target Chain 24	UniProt (SwissProt) Secondary ID(s) of Target Chain 24	UniProt (SwissProt) Alternative ID(s) of Target Chain 24	UniProt (TrEMBL) Submitted Name of Target Chain 24	UniProt (TrEMBL) Entry Name of Target Chain 24	UniProt (TrEMBL) Primary ID of Target Chain 24	UniProt (TrEMBL) Secondary ID(s) of Target Chain 24	UniProt (TrEMBL) Alternative ID(s) of Target Chain 24	BindingDB Target Chain Sequence 25	PDB ID(s) of Target Chain 25	UniProt (SwissProt) Recommended Name of Target Chain 25	UniProt (SwissProt) Entry Name of Target Chain 25	UniProt (SwissProt) Primary ID of Target Chain 25	UniProt (SwissProt) Secondary ID(s) of Target Chain 25	UniProt (SwissProt) Alternative ID(s) of Target Chain 25	UniProt (TrEMBL) Submitted Name of Target Chain 25	UniProt (TrEMBL) Entry Name of Target Chain 25	UniProt (TrEMBL) Primary ID of Target Chain 25	UniProt (TrEMBL) Secondary ID(s) of Target Chain 25	UniProt (TrEMBL) Alternative ID(s) of Target Chain 25	BindingDB Target Chain Sequence 26	PDB ID(s) of Target Chain 26	UniProt (SwissProt) Recommended Name of Target Chain 26	UniProt (SwissProt) Entry Name of Target Chain 26	UniProt (SwissProt) Primary ID of Target Chain 26	UniProt (SwissProt) Secondary ID(s) of Target Chain 26	UniProt (SwissProt) Alternative ID(s) of Target Chain 26	UniProt (TrEMBL) Submitted Name of Target Chain 26	UniProt (TrEMBL) Entry Name of Target Chain 26	UniProt (TrEMBL) Primary ID of Target Chain 26	UniProt (TrEMBL) Secondary ID(s) of Target Chain 26	UniProt (TrEMBL) Alternative ID(s) of Target Chain 26	BindingDB Target Chain Sequence 27	PDB ID(s) of Target Chain 27	UniProt (SwissProt) Recommended Name of Target Chain 27	UniProt (SwissProt) Entry Name of Target Chain 27	UniProt (SwissProt) Primary ID of Target Chain 27	UniProt (SwissProt) Secondary ID(s) of Target Chain 27	UniProt (SwissProt) Alternative ID(s) of Target Chain 27	UniProt (TrEMBL) Submitted Name of Target Chain 27	UniProt (TrEMBL) Entry Name of Target Chain 27	UniProt (TrEMBL) Primary ID of Target Chain 27	UniProt (TrEMBL) Secondary ID(s) of Target Chain 27	UniProt (TrEMBL) Alternative ID(s) of Target Chain 27	BindingDB Target Chain Sequence 28	PDB ID(s) of Target Chain 28	UniProt (SwissProt) Recommended Name of Target Chain 28	UniProt (SwissProt) Entry Name of Target Chain 28	UniProt (SwissProt) Primary ID of Target Chain 28	UniProt (SwissProt) Secondary ID(s) of Target Chain 28	UniProt (SwissProt) Alternative ID(s) of Target Chain 28	UniProt (TrEMBL) Submitted Name of Target Chain 28	UniProt (TrEMBL) Entry Name of Target Chain 28	UniProt (TrEMBL) Primary ID of Target Chain 28	UniProt (TrEMBL) Secondary ID(s) of Target Chain 28	UniProt (TrEMBL) Alternative ID(s) of Target Chain 28	BindingDB Target Chain Sequence 29	PDB ID(s) of Target Chain 29	UniProt (SwissProt) Recommended Name of Target Chain 29	UniProt (SwissProt) Entry Name of Target Chain 29	UniProt (SwissProt) Primary ID of Target Chain 29	UniProt (SwissProt) Secondary ID(s) of Target Chain 29	UniProt (SwissProt) Alternative ID(s) of Target Chain 29	UniProt (TrEMBL) Submitted Name of Target Chain 29	UniProt (TrEMBL) Entry Name of Target Chain 29	UniProt (TrEMBL) Primary ID of Target Chain 29	UniProt (TrEMBL) Secondary ID(s) of Target Chain 29	UniProt (TrEMBL) Alternative ID(s) of Target Chain 29	BindingDB Target Chain Sequence 30	PDB ID(s) of Target Chain 30	UniProt (SwissProt) Recommended Name of Target Chain 30	UniProt (SwissProt) Entry Name of Target Chain 30	UniProt (SwissProt) Primary ID of Target Chain 30	UniProt (SwissProt) Secondary ID(s) of Target Chain 30	UniProt (SwissProt) Alternative ID(s) of Target Chain 30	UniProt (TrEMBL) Submitted Name of Target Chain 30	UniProt (TrEMBL) Entry Name of Target Chain 30	UniProt (TrEMBL) Primary ID of Target Chain 30	UniProt (TrEMBL) Secondary ID(s) of Target Chain 30	UniProt (TrEMBL) Alternative ID(s) of Target Chain 30	BindingDB Target Chain Sequence 31	PDB ID(s) of Target Chain 31	UniProt (SwissProt) Recommended Name of Target Chain 31	UniProt (SwissProt) Entry Name of Target Chain 31	UniProt (SwissProt) Primary ID of Target Chain 31	UniProt (SwissProt) Secondary ID(s) of Target Chain 31	UniProt (SwissProt) Alternative ID(s) of Target Chain 31	UniProt (TrEMBL) Submitted Name of Target Chain 31	UniProt (TrEMBL) Entry Name of Target Chain 31	UniProt (TrEMBL) Primary ID of Target Chain 31	UniProt (TrEMBL) Secondary ID(s) of Target Chain 31	UniProt (TrEMBL) Alternative ID(s) of Target Chain 31	BindingDB Target Chain Sequence 32	PDB ID(s) of Target Chain 32	UniProt (SwissProt) Recommended Name of Target Chain 32	UniProt (SwissProt) Entry Name of Target Chain 32	UniProt (SwissProt) Primary ID of Target Chain 32	UniProt (SwissProt) Secondary ID(s) of Target Chain 32	UniProt (SwissProt) Alternative ID(s) of Target Chain 32	UniProt (TrEMBL) Submitted Name of Target Chain 32	UniProt (TrEMBL) Entry Name of Target Chain 32	UniProt (TrEMBL) Primary ID of Target Chain 32	UniProt (TrEMBL) Secondary ID(s) of Target Chain 32	UniProt (TrEMBL) Alternative ID(s) of Target Chain 32	BindingDB Target Chain Sequence 33	PDB ID(s) of Target Chain 33	UniProt (SwissProt) Recommended Name of Target Chain 33	UniProt (SwissProt) Entry Name of Target Chain 33	UniProt (SwissProt) Primary ID of Target Chain 33	UniProt (SwissProt) Secondary ID(s) of Target Chain 33	UniProt (SwissProt) Alternative ID(s) of Target Chain 33	UniProt (TrEMBL) Submitted Name of Target Chain 33	UniProt (TrEMBL) Entry Name of Target Chain 33	UniProt (TrEMBL) Primary ID of Target Chain 33	UniProt (TrEMBL) Secondary ID(s) of Target Chain 33	UniProt (TrEMBL) Alternative ID(s) of Target Chain 33	BindingDB Target Chain Sequence 34	PDB ID(s) of Target Chain 34	UniProt (SwissProt) Recommended Name of Target Chain 34	UniProt (SwissProt) Entry Name of Target Chain 34	UniProt (SwissProt) Primary ID of Target Chain 34	UniProt (SwissProt) Secondary ID(s) of Target Chain 34	UniProt (SwissProt) Alternative ID(s) of Target Chain 34	UniProt (TrEMBL) Submitted Name of Target Chain 34	UniProt (TrEMBL) Entry Name of Target Chain 34	UniProt (TrEMBL) Primary ID of Target Chain 34	UniProt (TrEMBL) Secondary ID(s) of Target Chain 34	UniProt (TrEMBL) Alternative ID(s) of Target Chain 34	BindingDB Target Chain Sequence 35	PDB ID(s) of Target Chain 35	UniProt (SwissProt) Recommended Name of Target Chain 35	UniProt (SwissProt) Entry Name of Target Chain 35	UniProt (SwissProt) Primary ID of Target Chain 35	UniProt (SwissProt) Secondary ID(s) of Target Chain 35	UniProt (SwissProt) Alternative ID(s) of Target Chain 35	UniProt (TrEMBL) Submitted Name of Target Chain 35	UniProt (TrEMBL) Entry Name of Target Chain 35	UniProt (TrEMBL) Primary ID of Target Chain 35	UniProt (TrEMBL) Secondary ID(s) of Target Chain 35	UniProt (TrEMBL) Alternative ID(s) of Target Chain 35	BindingDB Target Chain Sequence 36	PDB ID(s) of Target Chain 36	UniProt (SwissProt) Recommended Name of Target Chain 36	UniProt (SwissProt) Entry Name of Target Chain 36	UniProt (SwissProt) Primary ID of Target Chain 36	UniProt (SwissProt) Secondary ID(s) of Target Chain 36	UniProt (SwissProt) Alternative ID(s) of Target Chain 36	UniProt (TrEMBL) Submitted Name of Target Chain 36	UniProt (TrEMBL) Entry Name of Target Chain 36	UniProt (TrEMBL) Primary ID of Target Chain 36	UniProt (TrEMBL) Secondary ID(s) of Target Chain 36	UniProt (TrEMBL) Alternative ID(s) of Target Chain 36	BindingDB Target Chain Sequence 37	PDB ID(s) of Target Chain 37	UniProt (SwissProt) Recommended Name of Target Chain 37	UniProt (SwissProt) Entry Name of Target Chain 37	UniProt (SwissProt) Primary ID of Target Chain 37	UniProt (SwissProt) Secondary ID(s) of Target Chain 37	UniProt (SwissProt) Alternative ID(s) of Target Chain 37	UniProt (TrEMBL) Submitted Name of Target Chain 37	UniProt (TrEMBL) Entry Name of Target Chain 37	UniProt (TrEMBL) Primary ID of Target Chain 37	UniProt (TrEMBL) Secondary ID(s) of Target Chain 37	UniProt (TrEMBL) Alternative ID(s) of Target Chain 37	BindingDB Target Chain Sequence 38	PDB ID(s) of Target Chain 38	UniProt (SwissProt) Recommended Name of Target Chain 38	UniProt (SwissProt) Entry Name of Target Chain 38	UniProt (SwissProt) Primary ID of Target Chain 38	UniProt (SwissProt) Secondary ID(s) of Target Chain 38	UniProt (SwissProt) Alternative ID(s) of Target Chain 38	UniProt (TrEMBL) Submitted Name of Target Chain 38	UniProt (TrEMBL) Entry Name of Target Chain 38	UniProt (TrEMBL) Primary ID of Target Chain 38	UniProt (TrEMBL) Secondary ID(s) of Target Chain 38	UniProt (TrEMBL) Alternative ID(s) of Target Chain 38	BindingDB Target Chain Sequence 39	PDB ID(s) of Target Chain 39	UniProt (SwissProt) Recommended Name of Target Chain 39	UniProt (SwissProt) Entry Name of Target Chain 39	UniProt (SwissProt) Primary ID of Target Chain 39	UniProt (SwissProt) Secondary ID(s) of Target Chain 39	UniProt (SwissProt) Alternative ID(s) of Target Chain 39	UniProt (TrEMBL) Submitted Name of Target Chain 39	UniProt (TrEMBL) Entry Name of Target Chain 39	UniProt (TrEMBL) Primary ID of Target Chain 39	UniProt (TrEMBL) Secondary ID(s) of Target Chain 39	UniProt (TrEMBL) Alternative ID(s) of Target Chain 39	BindingDB Target Chain Sequence 40	PDB ID(s) of Target Chain 40	UniProt (SwissProt) Recommended Name of Target Chain 40	UniProt (SwissProt) Entry Name of Target Chain 40	UniProt (SwissProt) Primary ID of Target Chain 40	UniProt (SwissProt) Secondary ID(s) of Target Chain 40	UniProt (SwissProt) Alternative ID(s) of Target Chain 40	UniProt (TrEMBL) Submitted Name of Target Chain 40	UniProt (TrEMBL) Entry Name of Target Chain 40	UniProt (TrEMBL) Primary ID of Target Chain 40	UniProt (TrEMBL) Secondary ID(s) of Target Chain 40	UniProt (TrEMBL) Alternative ID(s) of Target Chain 40	BindingDB Target Chain Sequence 41	PDB ID(s) of Target Chain 41	UniProt (SwissProt) Recommended Name of Target Chain 41	UniProt (SwissProt) Entry Name of Target Chain 41	UniProt (SwissProt) Primary ID of Target Chain 41	UniProt (SwissProt) Secondary ID(s) of Target Chain 41	UniProt (SwissProt) Alternative ID(s) of Target Chain 41	UniProt (TrEMBL) Submitted Name of Target Chain 41	UniProt (TrEMBL) Entry Name of Target Chain 41	UniProt (TrEMBL) Primary ID of Target Chain 41	UniProt (TrEMBL) Secondary ID(s) of Target Chain 41	UniProt (TrEMBL) Alternative ID(s) of Target Chain 41	BindingDB Target Chain Sequence 42	PDB ID(s) of Target Chain 42	UniProt (SwissProt) Recommended Name of Target Chain 42	UniProt (SwissProt) Entry Name of Target Chain 42	UniProt (SwissProt) Primary ID of Target Chain 42	UniProt (SwissProt) Secondary ID(s) of Target Chain 42	UniProt (SwissProt) Alternative ID(s) of Target Chain 42	UniProt (TrEMBL) Submitted Name of Target Chain 42	UniProt (TrEMBL) Entry Name of Target Chain 42	UniProt (TrEMBL) Primary ID of Target Chain 42	UniProt (TrEMBL) Secondary ID(s) of Target Chain 42	UniProt (TrEMBL) Alternative ID(s) of Target Chain 42	BindingDB Target Chain Sequence 43	PDB ID(s) of Target Chain 43	UniProt (SwissProt) Recommended Name of Target Chain 43	UniProt (SwissProt) Entry Name of Target Chain 43	UniProt (SwissProt) Primary ID of Target Chain 43	UniProt (SwissProt) Secondary ID(s) of Target Chain 43	UniProt (SwissProt) Alternative ID(s) of Target Chain 43	UniProt (TrEMBL) Submitted Name of Target Chain 43	UniProt (TrEMBL) Entry Name of Target Chain 43	UniProt (TrEMBL) Primary ID of Target Chain 43	UniProt (TrEMBL) Secondary ID(s) of Target Chain 43	UniProt (TrEMBL) Alternative ID(s) of Target Chain 43	BindingDB Target Chain Sequence 44	PDB ID(s) of Target Chain 44	UniProt (SwissProt) Recommended Name of Target Chain 44	UniProt (SwissProt) Entry Name of Target Chain 44	UniProt (SwissProt) Primary ID of Target Chain 44	UniProt (SwissProt) Secondary ID(s) of Target Chain 44	UniProt (SwissProt) Alternative ID(s) of Target Chain 44	UniProt (TrEMBL) Submitted Name of Target Chain 44	UniProt (TrEMBL) Entry Name of Target Chain 44	UniProt (TrEMBL) Primary ID of Target Chain 44	UniProt (TrEMBL) Secondary ID(s) of Target Chain 44	UniProt (TrEMBL) Alternative ID(s) of Target Chain 44	BindingDB Target Chain Sequence 45	PDB ID(s) of Target Chain 45	UniProt (SwissProt) Recommended Name of Target Chain 45	UniProt (SwissProt) Entry Name of Target Chain 45	UniProt (SwissProt) Primary ID of Target Chain 45	UniProt (SwissProt) Secondary ID(s) of Target Chain 45	UniProt (SwissProt) Alternative ID(s) of Target Chain 45	UniProt (TrEMBL) Submitted Name of Target Chain 45	UniProt (TrEMBL) Entry Name of Target Chain 45	UniProt (TrEMBL) Primary ID of Target Chain 45	UniProt (TrEMBL) Secondary ID(s) of Target Chain 45	UniProt (TrEMBL) Alternative ID(s) of Target Chain 45	BindingDB Target Chain Sequence 46	PDB ID(s) of Target Chain 46	UniProt (SwissProt) Recommended Name of Target Chain 46	UniProt (SwissProt) Entry Name of Target Chain 46	UniProt (SwissProt) Primary ID of Target Chain 46	UniProt (SwissProt) Secondary ID(s) of Target Chain 46	UniProt (SwissProt) Alternative ID(s) of Target Chain 46	UniProt (TrEMBL) Submitted Name of Target Chain 46	UniProt (TrEMBL) Entry Name of Target Chain 46	UniProt (TrEMBL) Primary ID of Target Chain 46	UniProt (TrEMBL) Secondary ID(s) of Target Chain 46	UniProt (TrEMBL) Alternative ID(s) of Target Chain 46	BindingDB Target Chain Sequence 47	PDB ID(s) of Target Chain 47	UniProt (SwissProt) Recommended Name of Target Chain 47	UniProt (SwissProt) Entry Name of Target Chain 47	UniProt (SwissProt) Primary ID of Target Chain 47	UniProt (SwissProt) Secondary ID(s) of Target Chain 47	UniProt (SwissProt) Alternative ID(s) of Target Chain 47	UniProt (TrEMBL) Submitted Name of Target Chain 47	UniProt (TrEMBL) Entry Name of Target Chain 47	UniProt (TrEMBL) Primary ID of Target Chain 47	UniProt (TrEMBL) Secondary ID(s) of Target Chain 47	UniProt (TrEMBL) Alternative ID(s) of Target Chain 47	BindingDB Target Chain Sequence 48	PDB ID(s) of Target Chain 48	UniProt (SwissProt) Recommended Name of Target Chain 48	UniProt (SwissProt) Entry Name of Target Chain 48	UniProt (SwissProt) Primary ID of Target Chain 48	UniProt (SwissProt) Secondary ID(s) of Target Chain 48	UniProt (SwissProt) Alternative ID(s) of Target Chain 48	UniProt (TrEMBL) Submitted Name of Target Chain 48	UniProt (TrEMBL) Entry Name of Target Chain 48	UniProt (TrEMBL) Primary ID of Target Chain 48	UniProt (TrEMBL) Secondary ID(s) of Target Chain 48	UniProt (TrEMBL) Alternative ID(s) of Target Chain 48	BindingDB Target Chain Sequence 49	PDB ID(s) of Target Chain 49	UniProt (SwissProt) Recommended Name of Target Chain 49	UniProt (SwissProt) Entry Name of Target Chain 49	UniProt (SwissProt) Primary ID of Target Chain 49	UniProt (SwissProt) Secondary ID(s) of Target Chain 49	UniProt (SwissProt) Alternative ID(s) of Target Chain 49	UniProt (TrEMBL) Submitted Name of Target Chain 49	UniProt (TrEMBL) Entry Name of Target Chain 49	UniProt (TrEMBL) Primary ID of Target Chain 49	UniProt (TrEMBL) Secondary ID(s) of Target Chain 49	UniProt (TrEMBL) Alternative ID(s) of Target Chain 49	BindingDB Target Chain Sequence 50	PDB ID(s) of Target Chain 50	UniProt (SwissProt) Recommended Name of Target Chain 50	UniProt (SwissProt) Entry Name of Target Chain 50	UniProt (SwissProt) Primary ID of Target Chain 50	UniProt (SwissProt) Secondary ID(s) of Target Chain 50	UniProt (SwissProt) Alternative ID(s) of Target Chain 50	UniProt (TrEMBL) Submitted Name of Target Chain 50	UniProt (TrEMBL) Entry Name of Target Chain 50	UniProt (TrEMBL) Primary ID of Target Chain 50	UniProt (TrEMBL) Secondary ID(s) of Target Chain 50	UniProt (TrEMBL) Alternative ID(s) of Target Chain 50
773703	Cc1ccc(cc1-c1ccc(NC(=O)c2c(F)cccc2F)cc1)C1=NOC(C)(C)C1=O	InChI=1S/C25H20F2N2O3/c1-14-7-8-16(22-23(30)25(2,3)32-29-22)13-18(14)15-9-11-17(12-10-15)28-24(31)21-19(26)5-4-6-20(21)27/h4-13H,1-3H3,(H,28,31)	QCIJFVBUOPDNBC-UHFFFAOYSA-N	387261	N-(5&#8242;- (5,5-Dimethyl-4-oxo- 4,5-dihydroisoxazol- 3-yl)-2&#8242;-methyl-[1,1&#8242;- biphenyl]-4-yl-2,6- difluorobenzamide::US10292981, Example 3	Interleukin-2	Human		<100.0							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387261	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387261&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			56958618	404856376							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773704	COc1ccc(cc1-c1ccc(NC(=O)c2snnc2C)cc1)C1=NOC(C)(C)C1=O	InChI=1S/C22H20N4O4S/c1-12-19(31-26-24-12)21(28)23-15-8-5-13(6-9-15)16-11-14(7-10-17(16)29-4)18-20(27)22(2,3)30-25-18/h5-11H,1-4H3,(H,23,28)	LMRKQWYLNWUYRW-UHFFFAOYSA-N	387262	N-(5&#8242;- (5,5-Dimethyl-4-oxo- 4,5-dihydroisoxazol- 3-yl)-2&#8242;-methoxy- [1,1&#8242;-biphenyl]-4-yl)- 4-methyl-1,2,3- thiadiazole-5- carboxamide::US10292981, Example 16	Interleukin-2	Human		<100.0							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387262	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387262&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			57330382	404856377							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773705	CC(=O)Nc1ccc(cc1-c1ccc(NC(=O)c2c(F)cccc2F)cc1)C1=NOC(C)(C)C1=O	InChI=1S/C26H21F2N3O4/c1-14(32)29-21-12-9-16(23-24(33)26(2,3)35-31-23)13-18(21)15-7-10-17(11-8-15)30-25(34)22-19(27)5-4-6-20(22)28/h4-13H,1-3H3,(H,29,32)(H,30,34)	OJFPHWNCWJVHFQ-UHFFFAOYSA-N	387263	N-(2&#8242;- acetamido-5&#8242;-(5,5- dimethyl-4-oxo-4,5- dihydroisoxazol-3- yl)-[1,1&#8242;-biphenyl]-4- yl)-2,6- difluorobenzamide::US10292981, Example 19	Interleukin-2	Human		<100.0							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387263	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387263&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			57330438	404856378							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773706	Cc1c(cccc1-c1ccc(NC(=O)c2c(F)cccc2F)cc1)C1=NOC(C)(C)C1=O	InChI=1S/C25H20F2N2O3/c1-14-17(6-4-7-18(14)22-23(30)25(2,3)32-29-22)15-10-12-16(13-11-15)28-24(31)21-19(26)8-5-9-20(21)27/h4-13H,1-3H3,(H,28,31)	NFSNROSXMGPXOR-UHFFFAOYSA-N	387264	N-(3&#8242;- (5,5-Dimethyl-4-oxo- 4,5-dihydroisoxazol- 3-yl)-2&#8242;-methyl-[1,1&#8242;- biphenyl]-4-yl)-2,6- difluorobenzamide::US10292981, Example 29	Interleukin-2	Human		<100.0							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387264	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387264&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			57330443	404856379							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773707	Cc1ccc(cc1-c1ccc(NC(=O)c2c(F)cccc2F)cc1)-c1nn(C)c(=O)o1	InChI=1S/C23H17F2N3O3/c1-13-6-7-15(22-27-28(2)23(30)31-22)12-17(13)14-8-10-16(11-9-14)26-21(29)20-18(24)4-3-5-19(20)25/h3-12H,1-2H3,(H,26,29)	NKLWMFLCTSEIFM-UHFFFAOYSA-N	387265	2,6- Difluoro-N-(2&#8242;- methyl-5&#8242;-(4-methyl- 5-oxo-4,5-dihydro- 1,3,4-oxadiazol-2-yl)- [1,1&#8242;-biphenyl]-4- yl)benzamide::US10292981, Example 33	Interleukin-2	Human		<100.0							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387265	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387265&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			89763695	404856380							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773708	CCn1nc(oc1=O)-c1ccc(C)c(c1)-c1ccc(NC(=O)c2c(F)cccc2F)cc1	InChI=1S/C24H19F2N3O3/c1-3-29-24(31)32-23(28-29)16-8-7-14(2)18(13-16)15-9-11-17(12-10-15)27-22(30)21-19(25)5-4-6-20(21)26/h4-13H,3H2,1-2H3,(H,27,30)	OWPMRXOYWPQBNY-UHFFFAOYSA-N	387266	N-(5&#8242;-  (4-Ethyl-5-oxo-4,5- dihydro-1,3,4-  oxadiazol-2-yl)-2&#8242;- methyl-[1,1&#8242;-  biphenyl]-4-yl)-2,6-  difluorobenzamide::US10292981, Example 34	Interleukin-2	Human		<100.0							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387266	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387266&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			67517275	404856381							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773709	COc1ccc(cc1-c1ccc(NC(=O)c2c(F)cccc2F)cc1)-c1nn(C)c(=O)o1	InChI=1S/C23H17F2N3O4/c1-28-23(30)32-22(27-28)14-8-11-19(31-2)16(12-14)13-6-9-15(10-7-13)26-21(29)20-17(24)4-3-5-18(20)25/h3-12H,1-2H3,(H,26,29)	OQWQDUSTDRSTKO-UHFFFAOYSA-N	387267	2,6- Difluoro-N-(2&#8242;- methoxy-5&#8242;-(4- methyl-5-oxo-4,5- dihydro-1,3,4- oxadiazol-2-yl)[1,1&#8242;- biphenyl]-4- yl)benzamide::US10292981, Example 40	Interleukin-2	Human		<100.0							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387267	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387267&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			57330501	404856382							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773710	Cn1nc(oc1=O)-c1ccc(Cl)c(c1)-c1ccc(NC(=O)c2c(F)cccc2F)cc1	InChI=1S/C22H14ClF2N3O3/c1-28-22(30)31-21(27-28)13-7-10-16(23)15(11-13)12-5-8-14(9-6-12)26-20(29)19-17(24)3-2-4-18(19)25/h2-11H,1H3,(H,26,29)	VBGWOAOSCPKNMD-UHFFFAOYSA-N	387268	N-(2&#8242;- Chloro-5&#8242;-(4-methyl- 5-oxo-4,5-dihydro- 1,3,4-oxadiazol-2-yl)- [1,1&#8242;-biphenyl]-4-yl)- 2,6- difluorobenzamide::US10292981, Example 46	Interleukin-2	Human		<100.0							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387268	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387268&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			57330504	404856383							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773711	Cc1ccc(cc1-c1cnc(NC(=O)c2c(F)cccc2Cl)cn1)C1=NOC(C)(C)C1=O	InChI=1S/C23H18ClFN4O3/c1-12-7-8-13(20-21(30)23(2,3)32-29-20)9-14(12)17-10-27-18(11-26-17)28-22(31)19-15(24)5-4-6-16(19)25/h4-11H,1-3H3,(H,27,28,31)	KFLVVCARMXCDDZ-UHFFFAOYSA-N	387269	2- Chloro-N-(5-(5-(5,5- dimethyl-4-oxo-4,5- dihydroisoxazol-3- yl)-2-methyl  phenyl)pyrazin-2-yl)- 6-fluorobenzamide::US10292981, Example 80	Interleukin-2	Human		<100.0							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387269	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387269&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			67515178	404856384							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773712	Cc1ccc(cc1-c1cnc(NC(=O)c2c(F)cccc2F)cn1)-c1nn(C)c(=O)o1	InChI=1S/C21H15F2N5O3/c1-11-6-7-12(20-27-28(2)21(30)31-20)8-13(11)16-9-25-17(10-24-16)26-19(29)18-14(22)4-3-5-15(18)23/h3-10H,1-2H3,(H,25,26,29)	NQLUEONWNDPITM-UHFFFAOYSA-N	387270	2,6- Difluoro-N-(5-(2- methyl-5-(4- methyl-5-oxo-4,5- dihydro-1,3,4- oxadiazol-2- yl)phenyl)pyrazin- 2-yl)benzamide::US10292981, Example 87	Interleukin-2	Human		<100.0							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387270	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387270&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			89763991	404856385							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773713	COc1ccc(cc1-c1cnc(NC(=O)c2c(F)cccc2F)cn1)-c1nn(C)c(=O)o1	InChI=1S/C21H15F2N5O4/c1-28-21(30)32-20(27-28)11-6-7-16(31-2)12(8-11)15-9-25-17(10-24-15)26-19(29)18-13(22)4-3-5-14(18)23/h3-10H,1-2H3,(H,25,26,29)	WBHMQSQHURVXPI-UHFFFAOYSA-N	387271	2,6- Difluoro-N-(5-(2- methoxy-5-(4- methyl-5-oxo-4,5- dihydro-1,3,4- oxadiazol-2- yl)phenyl)pyrazin- 2-yl)benzamide::US10292981, Example 93	Interleukin-2	Human		<100.0							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387271	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387271&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			67515017	404856386							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773714	Cc1ccc(cc1-c1cnc(NC(=O)c2c(F)cncc2F)cn1)C1=NOC(C)(C)C1=O	InChI=1S/C22H17F2N5O3/c1-11-4-5-12(19-20(30)22(2,3)32-29-19)6-13(11)16-9-27-17(10-26-16)28-21(31)18-14(23)7-25-8-15(18)24/h4-10H,1-3H3,(H,27,28,31)	VWWZLAHHWMLIIM-UHFFFAOYSA-N	387272	N-(5-(5- (5,5-dimethyl-4-oxo- 4,5-dihydroisoxazol-3- yl)-2- methylphenyl)pyrazin- 2-yl)-3,5- difluoroisonicotinamide::US10292981, Example 114	Interleukin-2	Human		<100.0							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387272	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387272&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			67515995	404856387							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773715	CNc1ccc(cc1-c1ccc(NC(=O)c2c(F)cccc2F)cc1)C1=NOC(C)(C)C1=O	InChI=1S/C25H21F2N3O3/c1-25(2)23(31)22(30-33-25)15-9-12-20(28-3)17(13-15)14-7-10-16(11-8-14)29-24(32)21-18(26)5-4-6-19(21)27/h4-13,28H,1-3H3,(H,29,32)	LDGXRCFIEHUTCC-UHFFFAOYSA-N	387273	US10292981, Example 135	Interleukin-2	Human		<100.0							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387273	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387273&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			67515392	404856388							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773716	CCc1ccc(cc1-c1ccc(s1)C(=O)Nc1c(F)cccc1F)C1=NOC(C)(C)C1=O	InChI=1S/C24H20F2N2O3S/c1-4-13-8-9-14(20-22(29)24(2,3)31-28-20)12-15(13)18-10-11-19(32-18)23(30)27-21-16(25)6-5-7-17(21)26/h5-12H,4H2,1-3H3,(H,27,30)	KZOWQKXJSZKILX-UHFFFAOYSA-N	387274	N-(2,6- Difluorophenyl)-5-(5- (5,5-dimethyl-4-oxo- 4,5-dihydroisoxazol- 3-yl)-2-ethyl- phenyl)thiophene- 2-carboxamide ::US10292981, Example 157	Interleukin-2	Human		<100.0							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387274	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387274&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			67514882	404856389							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773717	CCc1ccc(cc1-c1ccc(s1)C(=O)Nc1ccncc1C)C1=NOC(C)(C)C1=O	InChI=1S/C24H23N3O3S/c1-5-15-6-7-16(21-22(28)24(3,4)30-27-21)12-17(15)19-8-9-20(31-19)23(29)26-18-10-11-25-13-14(18)2/h6-13H,5H2,1-4H3,(H,25,26,29)	BPEWWUFHHJJALF-UHFFFAOYSA-N	387276	5-(5- (5,5-Dimethyl-4-oxo- 4,5-dihydroisoxazol- 3-yl)-2-ethylphenyl)- N-(3-methylpyridin- 4-yl)thiophene-2- carboxamide ::US10292981, Example 158	Interleukin-2	Human		<100.0							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387276	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387276&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			67515850	404856391							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773718	COc1ccc(cc1-c1ccc(s1)C(=O)Nc1c(F)cccc1F)C1=NOC(C)(C)C1=O	InChI=1S/C23H18F2N2O4S/c1-23(2)21(28)19(27-31-23)12-7-8-16(30-3)13(11-12)17-9-10-18(32-17)22(29)26-20-14(24)5-4-6-15(20)25/h4-11H,1-3H3,(H,26,29)	ZAKLURTYMKCKHA-UHFFFAOYSA-N	387277	N-(2,6- Difluorophenyl)-5-(5- (5,5-dimethyl-4-oxo- 4,5-dihydroisoxazol- 3-yl)-2-methoxy- phenyl)thiophene- 2-carboxamide ::US10292981, Example 160	Interleukin-2	Human		<100.0							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387277	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387277&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			67515433	404856392							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773719	CCc1ccc(cc1-c1ccc(s1)C(=O)Nc1c(F)cccc1F)-c1nn(C)c(=O)o1	InChI=1S/C22H17F2N3O3S/c1-3-12-7-8-13(21-26-27(2)22(29)30-21)11-14(12)17-9-10-18(31-17)20(28)25-19-15(23)5-4-6-16(19)24/h4-11H,3H2,1-2H3,(H,25,28)	OOGAUNBWNNRQGA-UHFFFAOYSA-N	387278	N-(2,6- Difluorophenyl)-5-(2- ethyl-5-(4-methyl-5- oxo-4,5-dihydro- 1,3,4-oxadiazol-2- yl)phenyl)thiophene- 2-carboxamide::US10292981, Example 171	Interleukin-2	Human		<100.0							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387278	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387278&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			57331142	404856393							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773720	Cn1nc(oc1=O)-c1ccc(OC(F)F)c(c1)-c1ccc(s1)C(=O)Nc1c(F)cccc1F	InChI=1S/C21H13F4N3O4S/c1-28-21(30)32-19(27-28)10-5-6-14(31-20(24)25)11(9-10)15-7-8-16(33-15)18(29)26-17-12(22)3-2-4-13(17)23/h2-9,20H,1H3,(H,26,29)	DXERDVIJRMRUCB-UHFFFAOYSA-N	387279	5-(2- (Difluoromethoxy)-5- (4-methyl-5-oxo-4,5- dihydro-1,3,4- oxadiazol-2- yl)phenyl)-N-(2,6- difluorophenyl) thiophene-2- carboxamide ::US10292981, Example 173	Interleukin-2	Human		<100.0							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387279	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387279&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			57331144	404856394							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773721	Cc1c(cccc1-c1nn(C)c(=O)o1)-c1ccc(s1)C(=O)Nc1c(F)cccc1F	InChI=1S/C21H15F2N3O3S/c1-11-12(5-3-6-13(11)20-25-26(2)21(28)29-20)16-9-10-17(30-16)19(27)24-18-14(22)7-4-8-15(18)23/h3-10H,1-2H3,(H,24,27)	RAZCHIWVZLUOQN-UHFFFAOYSA-N	387280	N-(2,6- Difluorophenyl)-5-(2- methyl-3-(4-methyl- 5-oxo-4,5-dihydro- 1,3,4-oxadiazol-2- yl)phenyl)thiophene- 2-carboxamide::US10292981, Example 176	Interleukin-2	Human		<100.0							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387280	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387280&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			57330266	404856395							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773722	Cc1ccc(cc1-c1ccc(NC(=O)c2c(F)cccc2F)nc1)C1=NOC(C)(C)C1=O	InChI=1S/C24H19F2N3O3/c1-13-7-8-14(21-22(30)24(2,3)32-29-21)11-16(13)15-9-10-19(27-12-15)28-23(31)20-17(25)5-4-6-18(20)26/h4-12H,1-3H3,(H,27,28,31)	BBFUAFQFQUCONY-UHFFFAOYSA-N	387281	N-(5-(5- (5,5-Dimethyl-4-oxo- 4,5-dihydroisoxazol- 3-yl)-2- methylphenyl)pyridin- 2-yl)-2,6- difluorobenzamide ::US10292981, Example 4	Interleukin-2	Human		 550							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387281	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387281&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			57330319	404856396							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773723	CCc1ccc(cc1-c1ccc(NC(=O)c2c(F)cccc2F)cn1)C1=NOC(C)(C)C1=O	InChI=1S/C25H21F2N3O3/c1-4-14-8-9-15(22-23(31)25(2,3)33-30-22)12-17(14)20-11-10-16(13-28-20)29-24(32)21-18(26)6-5-7-19(21)27/h5-13H,4H2,1-3H3,(H,29,32)	AXZKCIIGEACCEC-UHFFFAOYSA-N	387282	N-(6-(5- (5,5-dimethyl-4-oxo- 4,5-dihydroisoxazol- 3-yl)-2- ethylphenyl)pyridin- 3-yl)-2,6- difluorobenzamide::US10292981, Example 7	Interleukin-2	Human		 550							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387282	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387282&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			57330321	404856397							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773724	CC(C)c1ccc(cc1-c1cnc(NC(=O)c2c(F)cccc2F)cn1)C1=NOC(C)(C)C1=O	InChI=1S/C25H22F2N4O3/c1-13(2)15-9-8-14(22-23(32)25(3,4)34-31-22)10-16(15)19-11-29-20(12-28-19)30-24(33)21-17(26)6-5-7-18(21)27/h5-13H,1-4H3,(H,29,30,33)	RTCKXTOTTYWPLF-UHFFFAOYSA-N	387283	N-(5-(5- (5,5-dimethyl-4-oxo- 4,5-dihydroisoxazol- 3-yl)-2- isopropylphenyl)pyrazin- 2-yl)-2,6- difluorobenzamide::US10292981, Example 8	Interleukin-2	Human		 550							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387283	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387283&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			67515311	404856398							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773725	CC1(C)ON=C(C1=O)c1ccc(Cl)c(c1)-c1ccc(NC(=O)c2c(F)cccc2F)cc1	InChI=1S/C24H17ClF2N2O3/c1-24(2)22(30)21(29-32-24)14-8-11-17(25)16(12-14)13-6-9-15(10-7-13)28-23(31)20-18(26)4-3-5-19(20)27/h3-12H,1-2H3,(H,28,31)	VPNVXPWEPKFNHD-UHFFFAOYSA-N	387284	N-(2&#8242;- chloro-5&#8242;-(5,5- dimethyl-4-oxo-4,5- dihydroisoxazol-3- yl)-[1,1&#8242;-biphenyl]-4- yl)-2,6- difluorobenzamide::US10292981, Example 11	Interleukin-2	Human		 550							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387284	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387284&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			57330380	404856399							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773726	COc1ccc(cc1-c1ccc(NC(=O)c2c(F)cccc2F)cn1)C1=NOC(C)(C)C1=O	InChI=1S/C24H19F2N3O4/c1-24(2)22(30)21(29-33-24)13-7-10-19(32-3)15(11-13)18-9-8-14(12-27-18)28-23(31)20-16(25)5-4-6-17(20)26/h4-12H,1-3H3,(H,28,31)	DZMUSTHWHKLETA-UHFFFAOYSA-N	387285	N-(6-(5- (5,5-dimethyl-4-oxo- 4,5-dihydroisoxazol- 3-yl)-2- methoxyphenyl)pyridin- 3-yl)-2,6- difluorobenzamide::US10292981, Example 18	Interleukin-2	Human		 550							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387285	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387285&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			67515792	404856400							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773727	COC1C(=NOC1(C)C)c1ccc(C)c(c1)-c1cnc(NC(=O)c2c(F)cccc2F)cn1	InChI=1S/C24H22F2N4O3/c1-13-8-9-14(21-22(32-4)24(2,3)33-30-21)10-15(13)18-11-28-19(12-27-18)29-23(31)20-16(25)6-5-7-17(20)26/h5-12,22H,1-4H3,(H,28,29,31)	RWYVQTQCSDNUNW-UHFFFAOYSA-N	387286	2,6- difluoro-N-(5-(5-(4- methoxy-5,5- dimethyl-4,5- dihydroisoxazol-3- yl)-2- methylphenyl)pyrazin- 2-yl)benzamide::US10292981, Example 23	Interleukin-2	Human		 550							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387286	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387286&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			57330440	404856401							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773728	COC1C(=NOC1(C)C)c1ccc(C)c(c1)-c1ccc(NC(=O)c2c(F)cccc2F)cc1	InChI=1S/C26H24F2N2O3/c1-15-8-9-17(23-24(32-4)26(2,3)33-30-23)14-19(15)16-10-12-18(13-11-16)29-25(31)22-20(27)6-5-7-21(22)28/h5-14,24H,1-4H3,(H,29,31)	OVAPXSYEFRBAPF-UHFFFAOYSA-N	387287	2,6- Difluoro-N-(5&#8242;-(4- methoxy-5,5- dimethyl-4,5- dihydroisoxazol-3- yl)-2&#8242;-methyl-[1,1&#8242;- biphenyl]-4- yl)benzamide::US10292981, Example 24	Interleukin-2	Human		 550							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387287	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387287&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			57330441	404856402							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773729	COc1c(cccc1-c1ccc(NC(=O)c2c(F)cccc2F)cc1)C1=NOC(C)(C)C1=O	InChI=1S/C25H20F2N2O4/c1-25(2)23(30)21(29-33-25)17-7-4-6-16(22(17)32-3)14-10-12-15(13-11-14)28-24(31)20-18(26)8-5-9-19(20)27/h4-13H,1-3H3,(H,28,31)	ATABWEVAFCJIRP-UHFFFAOYSA-N	387288	N-(3&#8242;- (5,5-Dimethyl-4-oxo- 4,5-dihydroisoxazol- 3-yl)-2&#8242;-methoxy- [1,1&#8242;-bipheny;]-4-yl)- 2,6- difluorobenzamide::US10292981, Example 31	Interleukin-2	Human		 550							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387288	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387288&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			67515701	404856403							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773730	Cc1ccc(cc1-c1cnc(NC(=O)c2cccnc2C)cn1)C1=NOC(C)(C)C1=O	InChI=1S/C23H21N5O3/c1-13-7-8-15(20-21(29)23(3,4)31-28-20)10-17(13)18-11-26-19(12-25-18)27-22(30)16-6-5-9-24-14(16)2/h5-12H,1-4H3,(H,26,27,30)	YICKYTIMRQDPKA-UHFFFAOYSA-N	387289	N-(5-(5- (5,5-dimethyl-4-oxo- 4,5-dihydroisoxazol-3- yl)-2- methylphenyl)pyrazin- 2-yl)-2- methylnicotinamide::US10292981, Example 113	Interleukin-2	Human		 550							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387289	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387289&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			57330779	404856404							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773731	Cc1ccc(cc1-c1cnc(NC(=O)c2c(F)cccc2F)cn1)C1=NOC(C)(C)C1	InChI=1S/C23H20F2N4O2/c1-13-7-8-14(18-10-23(2,3)31-29-18)9-15(13)19-11-27-20(12-26-19)28-22(30)21-16(24)5-4-6-17(21)25/h4-9,11-12H,10H2,1-3H3,(H,27,28,30)	DREFJQDUVPJVKI-UHFFFAOYSA-N	387290	N-(5- (5,5-Dimethyl-4,5- dihydroisoxazol-3- yl)-2- methylphenyl)pyrazin- 2-yl)-2,6- difluorobenzamide::US10292981, Example 53	Interleukin-2	Human		 550							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387290	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387290&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			89771956	404856405							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773732	Cc1ccc(cc1-c1ccc(NC(=O)c2c(F)cccc2F)cc1)C1=NOC2(CCCCC2)C1=O	InChI=1S/C28H24F2N2O3/c1-17-8-9-19(25-26(33)28(35-32-25)14-3-2-4-15-28)16-21(17)18-10-12-20(13-11-18)31-27(34)24-22(29)6-5-7-23(24)30/h5-13,16H,2-4,14-15H2,1H3,(H,31,34)	CYDWCBHDCLFFMC-UHFFFAOYSA-N	387291	2,6- Difluoro-N-(2&#8242;- methyl-5&#8242;-(4-oxo-1- oxa-2- azaspiro[4.5]dec-2- en-3-yl)-[1,1&#8242;- biphenyl]-4- yl)benzamide::US10292981, Example 58	Interleukin-2	Human		 550							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387291	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387291&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			89763854	404856406							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773733	Cc1ccc(cc1-c1ccc(NC(=O)c2c(F)cccc2F)cc1)C1=NC(C)(C)CO1	InChI=1S/C25H22F2N2O2/c1-15-7-8-17(24-29-25(2,3)14-31-24)13-19(15)16-9-11-18(12-10-16)28-23(30)22-20(26)5-4-6-21(22)27/h4-13H,14H2,1-3H3,(H,28,30)	AKWLXQBLZVKWTA-UHFFFAOYSA-N	387292	N-(5&#8242;-  (4,4-dimethyl-4,5- dihydrooxazol-2-yl)- 2&#8242;-methyl-[1,1&#8242;- biphenyl]-4-yl)-2,6- difluorobenzamide::US10292981, Example 61	Interleukin-2	Human		 550							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387292	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387292&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			67515666	404856407							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773734	Cc1ccc(cc1-c1cnc(NC(=O)c2cc(F)ccc2F)cn1)C1=NOC(C)(C)C1=O	InChI=1S/C23H18F2N4O3/c1-12-4-5-13(20-21(30)23(2,3)32-29-20)8-15(12)18-10-27-19(11-26-18)28-22(31)16-9-14(24)6-7-17(16)25/h4-11H,1-3H3,(H,27,28,31)	LIXKWKSOEHBXRI-UHFFFAOYSA-N	387293	N-(5-(5- (5,5-Dimethyl-4-oxo- 4,5-dihydroisoxazol- 3-yl)-2- methylphenyl)pyrazine- 2-yl)-2,5- difluorobenzamide::US10292981, Example 67	Interleukin-2	Human		 550							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387293	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387293&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			69675936	404856408							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773735	Cc1ccc(cc1-c1cnc(NC(=O)c2ccccc2Cl)cn1)C1=NOC(C)(C)C1=O	InChI=1S/C23H19ClN4O3/c1-13-8-9-14(20-21(29)23(2,3)31-28-20)10-16(13)18-11-26-19(12-25-18)27-22(30)15-6-4-5-7-17(15)24/h4-12H,1-3H3,(H,26,27,30)	GDPDBPBRFMYPNO-UHFFFAOYSA-N	387294	US10292981, Example 78	Interleukin-2	Human		 550							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387294	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387294&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			57330623	404856409							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773736	Cc1ccc(cc1-c1cnc(NC(=O)c2c(Cl)cncc2Cl)cn1)C1=NOC(C)(C)C1=O	InChI=1S/C22H17Cl2N5O3/c1-11-4-5-12(19-20(30)22(2,3)32-29-19)6-13(11)16-9-27-17(10-26-16)28-21(31)18-14(23)7-25-8-15(18)24/h4-10H,1-3H3,(H,27,28,31)	HLZWGPWIRVRBGR-UHFFFAOYSA-N	387295	3,5- Dichloro-N-(5-(5-(5,5- dimethyl-4-oxo-4,5- dihydroisoxazol-3- yl)-2- methylphenyl)pyrazin- 2-yl)isonicotinamide::US10292981, Example 103	Interleukin-2	Human		 550							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387295	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387295&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			57330681	404856410							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773737	Cc1ccc(cc1-c1cnc(NC(=O)c2ccncc2F)cn1)C1=NOC(C)(C)C1=O	InChI=1S/C22H18FN5O3/c1-12-4-5-13(19-20(29)22(2,3)31-28-19)8-15(12)17-10-26-18(11-25-17)27-21(30)14-6-7-24-9-16(14)23/h4-11H,1-3H3,(H,26,27,30)	OFWLFXZYHKJIML-UHFFFAOYSA-N	387296	N-(5-(5- (5,5-dimethyl-4-oxo- 4,5-dihydroisoxazol- 3-yl)-2- methylphenyl)pyrazin- 2-yl)-3- fluoroisonicotinamide::US10292981, Example 107	Interleukin-2	Human		 550							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387296	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387296&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			57330733	404856411							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773738	Cc1ccc(cc1-c1cnc(cn1)C(=O)Nc1c(F)cccc1F)C1=NOC(C)(C)C1=O	InChI=1S/C23H18F2N4O3/c1-12-7-8-13(19-21(30)23(2,3)32-29-19)9-14(12)17-10-27-18(11-26-17)22(31)28-20-15(24)5-4-6-16(20)25/h4-11H,1-3H3,(H,28,31)	KDVVIMMGQHFHBT-UHFFFAOYSA-N	387297	US10292981, Example 121	Interleukin-2	Human		 550							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387297	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387297&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			57330782	404856412							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773739	CC(C)Oc1ccc(cc1-c1cnc(NC(=O)c2c(F)cccc2F)cn1)C1=NOC(C)(C)C1=O	InChI=1S/C25H22F2N4O4/c1-13(2)34-19-9-8-14(22-23(32)25(3,4)35-31-22)10-15(19)18-11-29-20(12-28-18)30-24(33)21-16(26)6-5-7-17(21)27/h5-13H,1-4H3,(H,29,30,33)	JQOXBCMPDSKKFV-UHFFFAOYSA-N	387299	N-(5-(5- (5,5-dimethyl-4-oxo- 4,5-dihydroisoxazol-3- yl)-2-isopropoxy- phenyl)pyrazin- 2-yl)-2,6- difluorobenzamide ::US10292981, Example 126	Interleukin-2	Human		 550							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387299	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387299&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			57330831	404856414							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773740	CC1(C)ON=C(C1=O)c1ccc(OCC=C)c(c1)-c1ccc(NC(=O)c2c(F)cccc2F)cc1	InChI=1S/C27H22F2N2O4/c1-4-14-34-22-13-10-17(24-25(32)27(2,3)35-31-24)15-19(22)16-8-11-18(12-9-16)30-26(33)23-20(28)6-5-7-21(23)29/h4-13,15H,1,14H2,2-3H3,(H,30,33)	CWKALAKQGXNNIP-UHFFFAOYSA-N	387301	N-(2&#8242;- (allyloxy)-5&#8242;-(5,5- dimethyl-4-oxo-4,5- dihydroisoxazol-3-yl)- [1,1&#8242;-biphenyl]-4-yl)- 2,6-difluorobenzamide ::US10292981, Example 132	Interleukin-2	Human		 550							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387301	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387301&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			57330834	404856416							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773741	CN(C)c1ccc(cc1-c1ccc(NC(=O)c2c(F)cccc2F)cc1)C1=NOC(C)(C)C1=O	InChI=1S/C26H23F2N3O3/c1-26(2)24(32)23(30-34-26)16-10-13-21(31(3)4)18(14-16)15-8-11-17(12-9-15)29-25(33)22-19(27)6-5-7-20(22)28/h5-14H,1-4H3,(H,29,33)	SUODEOOJCNLTFN-UHFFFAOYSA-N	387306	US10292981, Example 136	Interleukin-2	Human		 550							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387306	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387306&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			57330891	404856421							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773742	Cc1c(cccc1-c1cnc(NC(=O)C2CCc3ccccc3C2)cn1)-c1nn(C)c(=O)o1	InChI=1S/C25H23N5O3/c1-15-19(8-5-9-20(15)24-29-30(2)25(32)33-24)21-13-27-22(14-26-21)28-23(31)18-11-10-16-6-3-4-7-17(16)12-18/h3-9,13-14,18H,10-12H2,1-2H3,(H,27,28,31)	UHSLDXRDGJQJQF-UHFFFAOYSA-N	387307	US10292981, Example 138	Interleukin-2	Human		 550							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387307	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387307&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			57330892	404856422							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773743	CC(C)(C)c1ccc(cc1-c1ccc(NC(=O)c2c(F)cccc2F)cc1)C1=NOC(C)(C)C1=O	InChI=1S/C28H26F2N2O3/c1-27(2,3)20-14-11-17(24-25(33)28(4,5)35-32-24)15-19(20)16-9-12-18(13-10-16)31-26(34)23-21(29)7-6-8-22(23)30/h6-15H,1-5H3,(H,31,34)	BGMDYWZEMGOCBS-UHFFFAOYSA-N	387308	N-(2&#8242;- (tert-butyl)-5&#8242;-(5,5- dimethyl-4-oxo-4,5- dihydroisoxazol-3- yl)-[1,1&#8242;-biphenyl]-4- yl)-2,6- difluorobenzamide::US10292981, Example 10	Interleukin-2	Human		>1000							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387308	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387308&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			57330379	404856423							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773744	COc1ccc(cc1-c1ccc(NC(=O)c2c(F)cccc2F)nc1)C1=NOC(C)(C)C1=O	InChI=1S/C24H19F2N3O4/c1-24(2)22(30)21(29-33-24)13-7-9-18(32-3)15(11-13)14-8-10-19(27-12-14)28-23(31)20-16(25)5-4-6-17(20)26/h4-12H,1-3H3,(H,27,28,31)	SZQXVNIKXBPIQX-UHFFFAOYSA-N	387309	N-(5-(5- (5,5-dimethyl-4-oxo-  4,5-dihydroisoxazol- 3-yl)-2- methoxyphenyl)pyridin- 2-yl)-2,6- difluorobenzamide::US10292981, Example 17	Interleukin-2	Human		>1000							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387309	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387309&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			57330383	404856424							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773745	Cc1ccc(cc1-c1cnc(NC(=O)c2ccc(F)cc2)cn1)C1=NOC(C)(C)C1=O	InChI=1S/C23H19FN4O3/c1-13-4-5-15(20-21(29)23(2,3)31-28-20)10-17(13)18-11-26-19(12-25-18)27-22(30)14-6-8-16(24)9-7-14/h4-12H,1-3H3,(H,26,27,30)	KCEQOYUWLJMBQM-UHFFFAOYSA-N	387310	N-(5-(5- (5,5-Dimethyl-4-oxo- 4,5-dihydroisoxazol- 3-yl)-2- methylphenyl)pyrazine- 2-yl)-4- fluorobenzamide::US10292981, Example 69	Interleukin-2	Human		>1000							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387310	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387310&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			67515485	404856425							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773746	Cc1ccc(cc1-c1ccc(NC(=O)c2c(F)cccc2F)cc1)C1=NOC(CO)(CCO)C1	InChI=1S/C26H24F2N2O4/c1-16-5-6-18(23-14-26(15-32,11-12-31)34-30-23)13-20(16)17-7-9-19(10-8-17)29-25(33)24-21(27)3-2-4-22(24)28/h2-10,13,31-32H,11-12,14-15H2,1H3,(H,29,33)	LXKNMMAJVDVTNY-UHFFFAOYSA-N	387312	2,6- Difluoro-N-(5&#8242;-(5-(2- hydroxyethyl)-5- (hydroxymethyl)-4,5- dihydroisoxazol-3-yl)- 2&#8242;-methyl-[1,1&#8242;- biphenyl]-4- yl)benzamide::US10292981, Example 145	Interleukin-2	Human		>1000							US Patent		10.7270/Q2D50Q8B		aid1798707	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387312	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6408&target=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387312&enzyme=Interleukin-2&column=ki&startPg=0&Increment=50&submit=Search			57330954	404856427							1	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT	1M47,1M48,1M49,1M4C,1PW6,1PY2,1QVN,1Z92,2B5I,5LQB,5UTZ,6YE3,7DR4,7M2G,7RA9	Interleukin-2	IL2_HUMAN	P60568	P01585																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773747	COc1ccc(cc1-c1ccc(NC(=O)c2c(F)cccc2F)cc1)C1=NOC(C)(C)C1=O	InChI=1S/C25H20F2N2O4/c1-25(2)23(30)22(29-33-25)15-9-12-20(32-3)17(13-15)14-7-10-16(11-8-14)28-24(31)21-18(26)5-4-6-19(21)27/h4-13H,1-3H3,(H,28,31)	HEQDPCXXOWPZQV-UHFFFAOYSA-N	387313	N-(5&#8242;-  (5,5-dimethyl-4-oxo- 4,5-dihydroisoxazol- 3-yl)-2&#8242;-methoxy-  [1,1&#8242;-biphenyl]-4-yl)- 2,6- difluorobenzamide::US10292981, Example 15	Store-operated calcium entry-associated regulatory factor	Human		<1000							US Patent		10.7270/Q2D50Q8B		aid1798708	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387313	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=668&target=Store-operated+calcium+entry-associated+regulatory+factor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387313&enzyme=Store-operated+calcium+entry-associated+regulatory+factor&column=ki&startPg=0&Increment=50&submit=Search			67515622	404856428							1	MAAACGPGAAGYCLLLGLHLFLLTAGPALGWNDPDRMLLRDVKALTLHYDRYTTSRRLDPIPQLKCVGGTAGCDSYTPKVIQCQNKGWDGYDVQWECKTDLDIAYKFGKTVVSCEGYESSEDQYVLRGSCGLEYNLDYTELGLQKLKESGKQHGFASFSDYYYKWSSADSCNMSGLITIVVLLGIAFVVYKLFLSDGQYSPPPYSEYPPFSHRYQRFTNSAGPPPPGFKSEFTGPQNTGHGATSGFGSAFTGQQGYENSGPGFWTGLGTGGILGYLFGSNRAATPFSDSWYYPSYPPSYPGTWNRAYSPLHGGSGSYSVCSNSDTKTRTASGYGGTRRR	6O2U						Store-operated calcium entry-associated regulatory factor	A0A140VK59_HUMAN	A0A140VK59																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
773748	COc1ccc(cc1-c1ccc(NC(=O)c2c(F)cccc2Cl)cc1)-c1nn(C)c(=O)o1	InChI=1S/C23H17ClFN3O4/c1-28-23(30)32-22(27-28)14-8-11-19(31-2)16(12-14)13-6-9-15(10-7-13)26-21(29)20-17(24)4-3-5-18(20)25/h3-12H,1-2H3,(H,26,29)	QLNGDLSYQBKAMN-UHFFFAOYSA-N	387314	2- Chloro-6-fluoro-N- (2&#8242;-methoxy-5&#8242;-(4- methyl-5-oxo-4,5- dihydro-1,3,4- oxadiazol-2-yl)[1,1&#8242;- biphenyl]-4- yl)benzamide::US10292981, Example 41	Store-operated calcium entry-associated regulatory factor	Human		<1000							US Patent		10.7270/Q2D50Q8B		aid1798708	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387314	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=668&target=Store-operated+calcium+entry-associated+regulatory+factor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387314&enzyme=Store-operated+calcium+entry-associated+regulatory+factor&column=ki&startPg=0&Increment=50&submit=Search			67517688	404856429							1	MAAACGPGAAGYCLLLGLHLFLLTAGPALGWNDPDRMLLRDVKALTLHYDRYTTSRRLDPIPQLKCVGGTAGCDSYTPKVIQCQNKGWDGYDVQWECKTDLDIAYKFGKTVVSCEGYESSEDQYVLRGSCGLEYNLDYTELGLQKLKESGKQHGFASFSDYYYKWSSADSCNMSGLITIVVLLGIAFVVYKLFLSDGQYSPPPYSEYPPFSHRYQRFTNSAGPPPPGFKSEFTGPQNTGHGATSGFGSAFTGQQGYENSGPGFWTGLGTGGILGYLFGSNRAATPFSDSWYYPSYPPSYPGTWNRAYSPLHGGSGSYSVCSNSDTKTRTASGYGGTRRR	6O2U						Store-operated calcium entry-associated regulatory factor	A0A140VK59_HUMAN	A0A140VK59																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
773749	CNc1ccc(cc1-c1ccc(NC(=O)c2c(F)cccc2F)cc1)C1=NOC(C)(C)C1=O	InChI=1S/C25H21F2N3O3/c1-25(2)23(31)22(30-33-25)15-9-12-20(28-3)17(13-15)14-7-10-16(11-8-14)29-24(32)21-18(26)5-4-6-19(21)27/h4-13,28H,1-3H3,(H,29,32)	LDGXRCFIEHUTCC-UHFFFAOYSA-N	387273	US10292981, Example 135	Store-operated calcium entry-associated regulatory factor	Human		<1000							US Patent		10.7270/Q2D50Q8B		aid1798708	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387273	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=668&target=Store-operated+calcium+entry-associated+regulatory+factor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387273&enzyme=Store-operated+calcium+entry-associated+regulatory+factor&column=ki&startPg=0&Increment=50&submit=Search			67515392	404856388							1	MAAACGPGAAGYCLLLGLHLFLLTAGPALGWNDPDRMLLRDVKALTLHYDRYTTSRRLDPIPQLKCVGGTAGCDSYTPKVIQCQNKGWDGYDVQWECKTDLDIAYKFGKTVVSCEGYESSEDQYVLRGSCGLEYNLDYTELGLQKLKESGKQHGFASFSDYYYKWSSADSCNMSGLITIVVLLGIAFVVYKLFLSDGQYSPPPYSEYPPFSHRYQRFTNSAGPPPPGFKSEFTGPQNTGHGATSGFGSAFTGQQGYENSGPGFWTGLGTGGILGYLFGSNRAATPFSDSWYYPSYPPSYPGTWNRAYSPLHGGSGSYSVCSNSDTKTRTASGYGGTRRR	6O2U						Store-operated calcium entry-associated regulatory factor	A0A140VK59_HUMAN	A0A140VK59																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
773750	COc1ccc(cc1-c1ccc(s1)C(=O)Nc1c(F)cccc1F)C1=NOC(C)(C)C1=O	InChI=1S/C23H18F2N2O4S/c1-23(2)21(28)19(27-31-23)12-7-8-16(30-3)13(11-12)17-9-10-18(32-17)22(29)26-20-14(24)5-4-6-15(20)25/h4-11H,1-3H3,(H,26,29)	ZAKLURTYMKCKHA-UHFFFAOYSA-N	387277	N-(2,6- Difluorophenyl)-5-(5- (5,5-dimethyl-4-oxo- 4,5-dihydroisoxazol- 3-yl)-2-methoxy- phenyl)thiophene- 2-carboxamide ::US10292981, Example 160	Store-operated calcium entry-associated regulatory factor	Human		<1000							US Patent		10.7270/Q2D50Q8B		aid1798708	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387277	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=668&target=Store-operated+calcium+entry-associated+regulatory+factor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387277&enzyme=Store-operated+calcium+entry-associated+regulatory+factor&column=ki&startPg=0&Increment=50&submit=Search			67515433	404856392							1	MAAACGPGAAGYCLLLGLHLFLLTAGPALGWNDPDRMLLRDVKALTLHYDRYTTSRRLDPIPQLKCVGGTAGCDSYTPKVIQCQNKGWDGYDVQWECKTDLDIAYKFGKTVVSCEGYESSEDQYVLRGSCGLEYNLDYTELGLQKLKESGKQHGFASFSDYYYKWSSADSCNMSGLITIVVLLGIAFVVYKLFLSDGQYSPPPYSEYPPFSHRYQRFTNSAGPPPPGFKSEFTGPQNTGHGATSGFGSAFTGQQGYENSGPGFWTGLGTGGILGYLFGSNRAATPFSDSWYYPSYPPSYPGTWNRAYSPLHGGSGSYSVCSNSDTKTRTASGYGGTRRR	6O2U						Store-operated calcium entry-associated regulatory factor	A0A140VK59_HUMAN	A0A140VK59																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
773751	Cc1c(cccc1-c1nn(C)c(=O)o1)-c1ccc(s1)C(=O)Nc1c(F)cccc1F	InChI=1S/C21H15F2N3O3S/c1-11-12(5-3-6-13(11)20-25-26(2)21(28)29-20)16-9-10-17(30-16)19(27)24-18-14(22)7-4-8-15(18)23/h3-10H,1-2H3,(H,24,27)	RAZCHIWVZLUOQN-UHFFFAOYSA-N	387280	N-(2,6- Difluorophenyl)-5-(2- methyl-3-(4-methyl- 5-oxo-4,5-dihydro- 1,3,4-oxadiazol-2- yl)phenyl)thiophene- 2-carboxamide::US10292981, Example 176	Store-operated calcium entry-associated regulatory factor	Human		<1000							US Patent		10.7270/Q2D50Q8B		aid1798708	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387280	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=668&target=Store-operated+calcium+entry-associated+regulatory+factor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387280&enzyme=Store-operated+calcium+entry-associated+regulatory+factor&column=ki&startPg=0&Increment=50&submit=Search			57330266	404856395							1	MAAACGPGAAGYCLLLGLHLFLLTAGPALGWNDPDRMLLRDVKALTLHYDRYTTSRRLDPIPQLKCVGGTAGCDSYTPKVIQCQNKGWDGYDVQWECKTDLDIAYKFGKTVVSCEGYESSEDQYVLRGSCGLEYNLDYTELGLQKLKESGKQHGFASFSDYYYKWSSADSCNMSGLITIVVLLGIAFVVYKLFLSDGQYSPPPYSEYPPFSHRYQRFTNSAGPPPPGFKSEFTGPQNTGHGATSGFGSAFTGQQGYENSGPGFWTGLGTGGILGYLFGSNRAATPFSDSWYYPSYPPSYPGTWNRAYSPLHGGSGSYSVCSNSDTKTRTASGYGGTRRR	6O2U						Store-operated calcium entry-associated regulatory factor	A0A140VK59_HUMAN	A0A140VK59																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
773752	Cc1c(cccc1-c1ccc(NC(=O)c2c(F)cccc2F)cc1)C1=NOC(C)(C)C1=O	InChI=1S/C25H20F2N2O3/c1-14-17(6-4-7-18(14)22-23(30)25(2,3)32-29-22)15-10-12-16(13-11-15)28-24(31)21-19(26)8-5-9-20(21)27/h4-13H,1-3H3,(H,28,31)	NFSNROSXMGPXOR-UHFFFAOYSA-N	387264	N-(3&#8242;- (5,5-Dimethyl-4-oxo- 4,5-dihydroisoxazol- 3-yl)-2&#8242;-methyl-[1,1&#8242;- biphenyl]-4-yl)-2,6- difluorobenzamide::US10292981, Example 29	Nuclear factor of activated T-cells, cytoplasmic 2	Human		<500							US Patent		10.7270/Q2D50Q8B		aid1798709	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387264	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=669&target=Nuclear+factor+of+activated+T-cells%2C+cytoplasmic+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387264&enzyme=Nuclear+factor+of+activated+T-cells%2C+cytoplasmic+2&column=ki&startPg=0&Increment=50&submit=Search			57330443	404856379							1	MNAPERQPQPDGGDAPGHEPGGSPQDELDFSILFDYEYLNPNEEEPNAHKVASPPSGPAYPDDVLDYGLKPYSPLASLSGEPPGRFGEPDRVGPQKFLSAAKPAGASGLSPRIEITPSHELIQAVGPLRMRDAGLLVEQPPLAGVAASPRFTLPVPGFEGYREPLCLSPASSGSSASFISDTFSPYTSPCVSPNNGGPDDLCPQFQNIPAHYSPRTSPIMSPRTSLAEDSCLGRHSPVPRPASRSSSPGAKRRHSCAEALVALPPGASPQRSRSPSPQPSSHVAPQDHGSPAGYPPVAGSAVIMDALNSLATDSPCGIPPKMWKTSPDPSPVSAAPSKAGLPRHIYPAVEFLGPCEQGERRNSAPESILLVPPTWPKPLVPAIPICSIPVTASLPPLEWPLSSQSGSYELRIEVQPKPHHRAHYETEGSRGAVKAPTGGHPVVQLHGYMENKPLGLQIFIGTADERILKPHAFYQVHRITGKTVTTTSYEKIVGNTKVLEIPLEPKNNMRATIDCAGILKLRNADIELRKGETDIGRKNTRVRLVFRVHIPESSGRIVSLQTASNPIECSQRSAHELPMVERQDTDSCLVYGGQQMILTGQNFTSESKVVFTEKTTDGQQIWEMEATVDKDKSQPNMLFVEIPEYRNKHIRTPVKVNFYVINGKRKRSQPQHFTYHPVPAIKTEPTDEYDPTLICSPTHGGLGSQPYYPQHPMVAESPSCLVATMAPCQQFRTGLSSPDARYQQQNPAAVLYQRSKSLSPSLLGYQQPALMAAPLSLADAHRSVLVHAGSQGQSSALLHPSPTNQQASPVIHYSPTNQQLRCGSHQEFQHIMYCENFAPGTTRPGPPPVSQGQRLSPGSYPTVIQQQNATSQRAAKNGPPVSDQKEVLPAGVTIKQEQNLDQTYLDDVNEIIRKEFSGPPARNQT	1OWR,1P7H,1S9K,2AS5,8OW4	Nuclear factor of activated T-cells, cytoplasmic 2	NFAC2_HUMAN	Q13469	B5B2N8 B5B2N9 B5B2P0 B5B2P2 B5B2P3 Q13468 Q5TFW7 Q5TFW8 Q9NPX6 Q9NQH3 Q9UJR2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773753	Cc1nnsc1C(=O)Nc1ccc(cc1)-c1cccc(-c2nn(C)c(=O)o2)c1C	InChI=1S/C20H17N5O3S/c1-11-15(5-4-6-16(11)19-23-25(3)20(27)28-19)13-7-9-14(10-8-13)21-18(26)17-12(2)22-24-29-17/h4-10H,1-3H3,(H,21,26)	KADFYAISZRMPTB-UHFFFAOYSA-N	387315	4- Methyl-N-(2&#8242;-methyl- 3&#8242;-(4-methyl-5-oxo- 4,5-dihydro-1,3,4- oxadiazol-2-yl)-[1,1&#8242;- biphenyl]-4-yl)-1,2,3- thiadiazole-5- carboxamide::US10292981, Example 50	Nuclear factor of activated T-cells, cytoplasmic 2	Human		<500							US Patent		10.7270/Q2D50Q8B		aid1798709	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387315	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=669&target=Nuclear+factor+of+activated+T-cells%2C+cytoplasmic+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387315&enzyme=Nuclear+factor+of+activated+T-cells%2C+cytoplasmic+2&column=ki&startPg=0&Increment=50&submit=Search			57330562	404856430							1	MNAPERQPQPDGGDAPGHEPGGSPQDELDFSILFDYEYLNPNEEEPNAHKVASPPSGPAYPDDVLDYGLKPYSPLASLSGEPPGRFGEPDRVGPQKFLSAAKPAGASGLSPRIEITPSHELIQAVGPLRMRDAGLLVEQPPLAGVAASPRFTLPVPGFEGYREPLCLSPASSGSSASFISDTFSPYTSPCVSPNNGGPDDLCPQFQNIPAHYSPRTSPIMSPRTSLAEDSCLGRHSPVPRPASRSSSPGAKRRHSCAEALVALPPGASPQRSRSPSPQPSSHVAPQDHGSPAGYPPVAGSAVIMDALNSLATDSPCGIPPKMWKTSPDPSPVSAAPSKAGLPRHIYPAVEFLGPCEQGERRNSAPESILLVPPTWPKPLVPAIPICSIPVTASLPPLEWPLSSQSGSYELRIEVQPKPHHRAHYETEGSRGAVKAPTGGHPVVQLHGYMENKPLGLQIFIGTADERILKPHAFYQVHRITGKTVTTTSYEKIVGNTKVLEIPLEPKNNMRATIDCAGILKLRNADIELRKGETDIGRKNTRVRLVFRVHIPESSGRIVSLQTASNPIECSQRSAHELPMVERQDTDSCLVYGGQQMILTGQNFTSESKVVFTEKTTDGQQIWEMEATVDKDKSQPNMLFVEIPEYRNKHIRTPVKVNFYVINGKRKRSQPQHFTYHPVPAIKTEPTDEYDPTLICSPTHGGLGSQPYYPQHPMVAESPSCLVATMAPCQQFRTGLSSPDARYQQQNPAAVLYQRSKSLSPSLLGYQQPALMAAPLSLADAHRSVLVHAGSQGQSSALLHPSPTNQQASPVIHYSPTNQQLRCGSHQEFQHIMYCENFAPGTTRPGPPPVSQGQRLSPGSYPTVIQQQNATSQRAAKNGPPVSDQKEVLPAGVTIKQEQNLDQTYLDDVNEIIRKEFSGPPARNQT	1OWR,1P7H,1S9K,2AS5,8OW4	Nuclear factor of activated T-cells, cytoplasmic 2	NFAC2_HUMAN	Q13469	B5B2N8 B5B2N9 B5B2P0 B5B2P2 B5B2P3 Q13468 Q5TFW7 Q5TFW8 Q9NPX6 Q9NQH3 Q9UJR2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773754	CNc1ccc(cc1-c1ccc(NC(=O)c2c(F)cccc2F)cc1)C1=NOC(C)(C)C1=O	InChI=1S/C25H21F2N3O3/c1-25(2)23(31)22(30-33-25)15-9-12-20(28-3)17(13-15)14-7-10-16(11-8-14)29-24(32)21-18(26)5-4-6-19(21)27/h4-13,28H,1-3H3,(H,29,32)	LDGXRCFIEHUTCC-UHFFFAOYSA-N	387273	US10292981, Example 135	Nuclear factor of activated T-cells, cytoplasmic 2	Human		<500							US Patent		10.7270/Q2D50Q8B		aid1798709	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387273	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=669&target=Nuclear+factor+of+activated+T-cells%2C+cytoplasmic+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387273&enzyme=Nuclear+factor+of+activated+T-cells%2C+cytoplasmic+2&column=ki&startPg=0&Increment=50&submit=Search			67515392	404856388							1	MNAPERQPQPDGGDAPGHEPGGSPQDELDFSILFDYEYLNPNEEEPNAHKVASPPSGPAYPDDVLDYGLKPYSPLASLSGEPPGRFGEPDRVGPQKFLSAAKPAGASGLSPRIEITPSHELIQAVGPLRMRDAGLLVEQPPLAGVAASPRFTLPVPGFEGYREPLCLSPASSGSSASFISDTFSPYTSPCVSPNNGGPDDLCPQFQNIPAHYSPRTSPIMSPRTSLAEDSCLGRHSPVPRPASRSSSPGAKRRHSCAEALVALPPGASPQRSRSPSPQPSSHVAPQDHGSPAGYPPVAGSAVIMDALNSLATDSPCGIPPKMWKTSPDPSPVSAAPSKAGLPRHIYPAVEFLGPCEQGERRNSAPESILLVPPTWPKPLVPAIPICSIPVTASLPPLEWPLSSQSGSYELRIEVQPKPHHRAHYETEGSRGAVKAPTGGHPVVQLHGYMENKPLGLQIFIGTADERILKPHAFYQVHRITGKTVTTTSYEKIVGNTKVLEIPLEPKNNMRATIDCAGILKLRNADIELRKGETDIGRKNTRVRLVFRVHIPESSGRIVSLQTASNPIECSQRSAHELPMVERQDTDSCLVYGGQQMILTGQNFTSESKVVFTEKTTDGQQIWEMEATVDKDKSQPNMLFVEIPEYRNKHIRTPVKVNFYVINGKRKRSQPQHFTYHPVPAIKTEPTDEYDPTLICSPTHGGLGSQPYYPQHPMVAESPSCLVATMAPCQQFRTGLSSPDARYQQQNPAAVLYQRSKSLSPSLLGYQQPALMAAPLSLADAHRSVLVHAGSQGQSSALLHPSPTNQQASPVIHYSPTNQQLRCGSHQEFQHIMYCENFAPGTTRPGPPPVSQGQRLSPGSYPTVIQQQNATSQRAAKNGPPVSDQKEVLPAGVTIKQEQNLDQTYLDDVNEIIRKEFSGPPARNQT	1OWR,1P7H,1S9K,2AS5,8OW4	Nuclear factor of activated T-cells, cytoplasmic 2	NFAC2_HUMAN	Q13469	B5B2N8 B5B2N9 B5B2P0 B5B2P2 B5B2P3 Q13468 Q5TFW7 Q5TFW8 Q9NPX6 Q9NQH3 Q9UJR2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
773755	Cc1c(cccc1-c1nn(C)c(=O)o1)-c1ccc(s1)C(=O)Nc1c(F)cccc1F	InChI=1S/C21H15F2N3O3S/c1-11-12(5-3-6-13(11)20-25-26(2)21(28)29-20)16-9-10-17(30-16)19(27)24-18-14(22)7-4-8-15(18)23/h3-10H,1-2H3,(H,24,27)	RAZCHIWVZLUOQN-UHFFFAOYSA-N	387280	N-(2,6- Difluorophenyl)-5-(2- methyl-3-(4-methyl- 5-oxo-4,5-dihydro- 1,3,4-oxadiazol-2- yl)phenyl)thiophene- 2-carboxamide::US10292981, Example 176	Nuclear factor of activated T-cells, cytoplasmic 2	Human		<500							US Patent		10.7270/Q2D50Q8B		aid1798709	US10292981	Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK	5/21/2019	3/10/2020	LUPIN LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=387280	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=669&target=Nuclear+factor+of+activated+T-cells%2C+cytoplasmic+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=387280&enzyme=Nuclear+factor+of+activated+T-cells%2C+cytoplasmic+2&column=ki&startPg=0&Increment=50&submit=Search			57330266	404856395							1	MNAPERQPQPDGGDAPGHEPGGSPQDELDFSILFDYEYLNPNEEEPNAHKVASPPSGPAYPDDVLDYGLKPYSPLASLSGEPPGRFGEPDRVGPQKFLSAAKPAGASGLSPRIEITPSHELIQAVGPLRMRDAGLLVEQPPLAGVAASPRFTLPVPGFEGYREPLCLSPASSGSSASFISDTFSPYTSPCVSPNNGGPDDLCPQFQNIPAHYSPRTSPIMSPRTSLAEDSCLGRHSPVPRPASRSSSPGAKRRHSCAEALVALPPGASPQRSRSPSPQPSSHVAPQDHGSPAGYPPVAGSAVIMDALNSLATDSPCGIPPKMWKTSPDPSPVSAAPSKAGLPRHIYPAVEFLGPCEQGERRNSAPESILLVPPTWPKPLVPAIPICSIPVTASLPPLEWPLSSQSGSYELRIEVQPKPHHRAHYETEGSRGAVKAPTGGHPVVQLHGYMENKPLGLQIFIGTADERILKPHAFYQVHRITGKTVTTTSYEKIVGNTKVLEIPLEPKNNMRATIDCAGILKLRNADIELRKGETDIGRKNTRVRLVFRVHIPESSGRIVSLQTASNPIECSQRSAHELPMVERQDTDSCLVYGGQQMILTGQNFTSESKVVFTEKTTDGQQIWEMEATVDKDKSQPNMLFVEIPEYRNKHIRTPVKVNFYVINGKRKRSQPQHFTYHPVPAIKTEPTDEYDPTLICSPTHGGLGSQPYYPQHPMVAESPSCLVATMAPCQQFRTGLSSPDARYQQQNPAAVLYQRSKSLSPSLLGYQQPALMAAPLSLADAHRSVLVHAGSQGQSSALLHPSPTNQQASPVIHYSPTNQQLRCGSHQEFQHIMYCENFAPGTTRPGPPPVSQGQRLSPGSYPTVIQQQNATSQRAAKNGPPVSDQKEVLPAGVTIKQEQNLDQTYLDDVNEIIRKEFSGPPARNQT	1OWR,1P7H,1S9K,2AS5,8OW4	Nuclear factor of activated T-cells, cytoplasmic 2	NFAC2_HUMAN	Q13469	B5B2N8 B5B2N9 B5B2P0 B5B2P2 B5B2P3 Q13468 Q5TFW7 Q5TFW8 Q9NPX6 Q9NQH3 Q9UJR2